Lesniak MS - Search Results

1

Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy.

Spencer DA, Auffinger BM, Murphy JP, Muroski ME, Qiao J, Gorind Y, Lesniak MS. Spencer DA, et al. Among authors: lesniak ms. Curr Cancer Drug Targets. 2017;17(3):236-254. doi: 10.2174/1568009616666161215161924. Curr Cancer Drug Targets. 2017. PMID: 27993114 Review.

2

Targeted therapy for brain tumours.

Lesniak MS, Brem H. Lesniak MS, et al. Nat Rev Drug Discov. 2004 Jun;3(6):499-508. doi: 10.1038/nrd1414. Nat Rev Drug Discov. 2004. PMID: 15173839 Review. No abstract available.

3

Immunotherapy for malignant glioma: current approaches and future directions.

Sikorski CW, Lesniak MS. Sikorski CW, et al. Among authors: lesniak ms. Neurol Res. 2005 Oct;27(7):703-16. doi: 10.1179/016164105X49481. Neurol Res. 2005. PMID: 16197807 Review.

4

Conditionally replicative adenoviral vectors for malignant glioma.

Sonabend AM, Ulasov IV, Lesniak MS. Sonabend AM, et al. Among authors: lesniak ms. Rev Med Virol. 2006 Mar-Apr;16(2):99-115. doi: 10.1002/rmv.490. Rev Med Virol. 2006. PMID: 16416455 Review.

5

Targeted therapy for malignant glioma: neural stem cells.

Lesniak MS. Lesniak MS. Expert Rev Neurother. 2006 Jan;6(1):1-3. doi: 10.1586/14737175.6.1.1. Expert Rev Neurother. 2006. PMID: 16466305 Review. No abstract available.

6

Gene therapy for malignant glioma.

Lesniak MS. Lesniak MS. Expert Rev Neurother. 2006 Apr;6(4):479-88. doi: 10.1586/14737175.6.4.479. Expert Rev Neurother. 2006. PMID: 16623647 Review.

7

Oncolytic adenoviral therapy for glioblastoma multiforme.

Sonabend AM, Ulasov IV, Han Y, Lesniak MS. Sonabend AM, et al. Among authors: lesniak ms. Neurosurg Focus. 2006 Apr 15;20(4):E19. Neurosurg Focus. 2006. PMID: 16709024 Review.

8

CD46 represents a target for adenoviral gene therapy of malignant glioma.

Ulasov IV, Tyler MA, Zheng S, Han Y, Lesniak MS. Ulasov IV, et al. Among authors: lesniak ms. Hum Gene Ther. 2006 May;17(5):556-64. doi: 10.1089/hum.2006.17.556. Hum Gene Ther. 2006. PMID: 16716112

9

An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.

El Andaloussi A, Lesniak MS. El Andaloussi A, et al. Among authors: lesniak ms. Neuro Oncol. 2006 Jul;8(3):234-43. doi: 10.1215/15228517-2006-006. Epub 2006 May 24. Neuro Oncol. 2006. PMID: 16723631 Free PMC article.

10

Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.

El Andaloussi A, Sonabend AM, Han Y, Lesniak MS. El Andaloussi A, et al. Among authors: lesniak ms. Glia. 2006 Nov 1;54(6):526-35. doi: 10.1002/glia.20401. Glia. 2006. PMID: 16906541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results